In a strategic move that signals growing momentum in healthcare investment, Waud Capital Partners announced three partner promotions and one principal advancement. The Chicago-based private equity firm, which started as a one-person operation in 1993, continues to solidify its position in specialized healthcare sectors under the guidance of founder Reeve Waud.
Tim Cremieux, who joined the firm in 2017, steps into his new partner role with significant achievements in pharmaceutical services. His recent work spearheading the PharmAlliance platform investment showcases the firm’s commitment to medication supply chain optimization. Cremieux also manages a portfolio that includes Apotheco and PromptCare, while keeping a watchful eye on emerging opportunities in wellness and functional medicine.
Kyle Lattner’s promotion to partner comes after a decade of dedication to Waud Capital’s healthcare initiatives. Since 2013, Lattner has played an instrumental role in shaping the firm’s healthcare services portfolio. His recent successes include leading investments in Senior Helpers and Mopec Group, while maintaining long-term oversight of APDerm and Ivy Rehab. Lattner’s expertise spans across medical device services, home care solutions, and behavioral health – sectors that align with Waud Capital’s growth strategy.
“We firmly believe that exceptional people drive exceptional value,” says Reeve Waud, reflecting on the promotions. This philosophy has guided the firm since its founding, leading to more than 480 successful investments across various sectors. The healthcare group, in particular, has seen remarkable growth under Waud’s leadership, including notable successes like Acadia Healthcare.
The healthcare team gains additional depth with Mike Lehman’s promotion to principal. Since joining in 2021, Lehman has contributed to the success of several key investments, including Unifeye Vision Partners and the firm’s newest addition, Mopec Group. His advancement reinforces Waud Capital’s practice of developing internal talent and maintaining deep sector expertise.
Chris Graber, Partner and Head of the Healthcare Group, points to these promotions as evidence of the firm’s successful talent development approach. “All of these new Partners have demonstrated extraordinary leadership, delivering value, insights and expertise to their portfolio companies,” Graber notes.
Looking ahead to 2025, these promotions position Waud Capital to capitalize on emerging healthcare opportunities. The firm’s focus on pharmaceutical services, behavioral health, and medical technology aligns with major industry trends. Under Reeve Waud’s continued leadership, the firm maintains its selective investment approach, typically deploying $75 million to $200 million in promising healthcare ventures.
From its early days at Lake Forest to its current position managing approximately $4.6 billion in assets, Waud Capital has maintained a steady focus on building market-leading companies. These latest promotions reflect both the firm’s growth and its commitment to developing healthcare expertise from within. As the healthcare sector continues to evolve, Waud Capital’s strengthened leadership team stands ready to identify and nurture the next generation of industry-leading companies.